Surrogate endpoints: the debate goes on

Pharmacoepidemiol Drug Saf. Oct-Nov 2001;10(6):493-6. doi: 10.1002/pds.655.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Acquired Immunodeficiency Syndrome / pathology
  • Acquired Immunodeficiency Syndrome / therapy
  • Arrhythmias, Cardiac / drug therapy
  • Biomarkers
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / therapy
  • Disease Progression
  • Endpoint Determination / methods*
  • Humans
  • Prognosis

Substances

  • Biomarkers